Federal Register / Vol. 75, No. 245 / Wednesday, December 22, 2010 / Notices 80507 

Dated: December 16, 2010. 

Catina Conner, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–32076 Filed 12–21–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60 Day–11–11BF] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instrument, call 404–639–5960 and send 

comments to Carol E. Walker, Acting 

CDC Reports Clearance Officer, 1600 

Clifton Road NE., MS–D74, Atlanta, 

Georgia 30333; or send an e-mail to 

omb@cdc.gov. 

Comments are invited on (a) whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have a 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Contact Investigation Outcome 

Reporting Forms—New—National 

Center for Emerging, Zoonotic and 

Infectious Diseases (NCEZID), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

CDC proposes to collect passengerlevel, epidemiologic, demographic, and 

health status data from State/local 

Health Departments and maritime 

operators at the conclusion of contact 

investigations of individuals believed to 

have been exposed to a communicable 

disease during travel. The information 

requested by CDC would be obtained by 

the health departments or maritime 

operators while conducting the contact 

investigation according to their 

established policies and procedures, 

and would be reported to CDC on a 

voluntary basis. This information will 

assist CDC in fulfilling its regulatory 

responsibility to prevent the 

importation of communicable diseases 

from foreign countries (42 CFR part 71) 

and interstate control of communicable 

diseases in humans (42 CFR part 70). To 

perform these tasks in a streamlined 

manner and ensure that all relevant 

information is collected in the most 

efficient and timely manner possible, 

Quarantine Stations use a number of 

forms: Contact Investigation Outcome 

Reporting Forms: (1) Optional TB Air/ 

Land Contact Investigation Outcome 

Reporting, (2) Optional Measles, 

Mumps, or Rubella Air/Land Contact 

Investigation Outcome Reporting, (3) 

Optional General Air/Land Contact 

Investigation Outcome Reporting Form, 

(4) Optional TB Maritime Contact 

Investigation Outcome Reporting Form, 

(5) Optional Measles, Mumps or Rubella 

Maritime Contact Investigation Outcome 

Reporting Form, (6) Optional General 

Maritime Contact Investigation Outcome 

Reporting Form. 

Section 361 of the Public Health 

Service (PHS) Act (42 USC 264) 

authorizes the Secretary of Health and 

Human Services to make and enforce 

regulations necessary to prevent the 

introduction, transmission or spread of 

communicable diseases from foreign 

countries into the United States. The 

regulations that implement this law, 42 

CFR parts 70 and 71, require 

conveyances to report an ‘‘ill person’’ or 

any death onboard to authorized 

quarantine officers and other personnel 

to inspect and undertake necessary 

control measures with respect to 

conveyances (e.g., airplanes, cruise 

ships), persons, and shipments of 

animals and etiologic agents in order to 

protect the public health. The 

notification is made possible by 

contacting individuals who may have 

been exposed to a communicable 

disease during travel and their contacts, 

and investigating this exposure so that 

the necessary medical or public health 

interventions can be implemented. 

CDC provides state and local health 

departments and maritime conveyance 

operators with information to notify and 

contact individuals and further 

investigate this exposure by contacting 

others who may have been potentially 

exposed to disease. However, there 

currently is no standardized tool or form 

to collect pertinent information 

regarding the outcome of such 

investigations. 

To address the need to inform CDC of 

additional actions that may be needed to 

further protect public health based on 

the outcome of the contact 

investigations, CDC has developed six 

forms to assist health departments and 

maritime conveyance operators in 

reporting back to CDC. The forms are 

specific to the nature of the 

investigation; Tuberculosis (TB), 

Measles, Mumps, and Rubella or the 

General forms specific to other diseases 

of public health concern. The purpose 

of the forms is the same: To collect 

information to help CDC quarantine 

officials to fully understand the extent 

of disease spread and transmission 

during travel and to inform the 

development and or refinement of 

investigative protocols, aimed at 

reducing the spread of communicable 

disease. 

All six forms collect the following 

categories of information: Heath status 

of traveler, clinical history including 

diagnosis, and interventions related to 

exposure. 

Respondents are state and local health 

departments and maritime conveyance 

operators. Respondents will use these 

standardized forms to submit data to 

CDC for each individual contacted via a 

secure means of their choice, e.g., Webbased application, fax or e-mail. 

The estimated total burden on the 

public, included in the chart below, can 

vary a great deal depending on the 

number of flights and the number of 

individuals identified as contacts that 

are assigned to a given health 

jurisdiction in the U.S. There is no cost 

to respondents other than their time. 


srobinson on DSKHWCL6B1PROD with NOTICES
80508 Federal Register / Vol. 75, No. 245 / Wednesday, December 22, 2010 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Forms Number of 

respondents 

Number of 

responses/ 

respondent 

Average 

burden/ 

response 

(in hours) 

Total burden 

hours 

State/Local health department staff .. Optional TB Air/Land Contact Investigation Outcome Reporting Form.2154 1 5/60 180 

State/Local health department staff .. Optional Measles, Mumps or Rubella Air/Land Contact Investigation 

Outcome Reporting Form.

367 1 5/60 31 

State/Local health department staff .. Optional General Air/Land Contact 

Investigation Outcome Reporting 

Form.

456 1 5/60 38 

Maritime Operators ........................... Optional TB Maritime Contact Investigation Outcome Reporting Form.190 1 5/60 16 

Maritime Operators ........................... Optional Measles, Mumps or Rubella Maritime Contact Investigation 

Outcome Reporting Form.

140 1 5/60 12 

Maritime Operators ........................... Optional General Maritime Contact 

Maritime Operators Investigation 

Outcome Reporting Form.

40 1 5/60 3 

Total ........................................... ........................................................... ........................ ........................ ........................ 280 

Dated: December 16, 2010. 

Catina Conner, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–32078 Filed 12–21–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Enabling Bioanalytical and Imaging 

Technologies. 

Date: December 29, 2010. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call.) 

Contact Person: Allen Richon, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6181, 

MSC 7892, Bethesda, MD 20892. 301–435– 

2902. allen.richon@nih.hhs.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Vascular and Hematology SEP. 

Date: January 10–11, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Bukhtiar H. Shah, DVM, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4120, 

MSC 7802, Bethesda, MD 20892. (301) 301 

806–7314. shahb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Diabetes, Obesity and Nutrition. 

Date: January 10, 2011. 

Time: 1p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: John Bleasdale, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6170, 

MSC 7892, Bethesda, MD 20892. 301–435– 

4514. bleasdaleje@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Small 

Business: Devices for the NICU. RFA HD10– 

012 and 013. 

Date: January 21, 2011. 

Time: 11 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda North Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: John Firrell, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5213, 

MSC 7854, Bethesda, MD 20892. 301–435– 

2598. firrellj@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: December 15, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–32100 Filed 12–21–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 


srobinson on DSKHWCL6B1PROD with NOTICES